Capital Cell ^Investors

Capital Cell is the world's leading alternative investment platform for biotechnology and life sciences companies. They offer crowdfunding and fundraising services, allowing investors to build the future of healthcare by supporting selected investments backed by industry leaders and experts. The platform is authorized and supervised by the National Securities Market Commission and holds a license from the European Securities and Markets Authority. Capital Cell connects investors with cutting-edge biotech and life sciences companies, such as Hemerion, which develops innovative therapies for cancer patients, and MSInsight, which utilizes advanced technology for disease management.